Literature DB >> 30409313

Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma.

Douglas J Hartman1, Fahad Ahmad2, Robert L Ferris3, David L Rimm2, Liron Pantanowitz4.   

Abstract

INTRODUCTION: In head and neck squamous cell carcinoma (HNSCC) high numbers of tumor infiltrating CD8 T cells in the tumor microenvironment are associated with better outcome. However, no investigators have employed automated image analysis on whole slide images to permit CD8 scores for use in clinical practice. The aim of this study was to develop and validate an image analysis algorithm to automatically quantify CD8 T cells in patients with oropharyngeal HNSCC.
MATERIALS AND METHODS: Using brightfield image analysis results were cross-validated with fluorescence based quantification (AQUA™). A nuclear image algorithm designed to run on whole slide images was optimized to manual count. The algorithm was locked down and used on a cohort of whole tissue sections from HNSCC patients. Multivariate clinicopathologic parameters and outcomes were statistically correlated with image analysis results.
RESULTS: Linear correlation between manual counts and the customized CD8 algorithm was 0.943. A total of 74 oropharyngeal HNSCC cases were analyzed for CD8 immune cell infiltrate using this image analysis algorithm. A CD8 immune cell density above 136 cells/mm2 was associated with median survival of 18 years compared to 5 years. When multivariate modeling was performed, HPV infection was the only predictor of survival; however, when HPV was excluded only CD8 cell density predicts survival.
CONCLUSIONS: We report the successful technical development and clinical validation of an image algorithm to automate CD8 immune cell density for oropharyngeal HNSCC. Employing brightfield image analysis on entire tumor sections instead of tumor subcompartments permits this strategy to be widely implemented.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD8; HPV; Head and neck; Image analysis; Immunology; Immunotherapy; Quantification; Score; Squamous cell carcinoma; Whole slide image

Year:  2018        PMID: 30409313      PMCID: PMC6260977          DOI: 10.1016/j.oraloncology.2018.10.005

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  26 in total

1.  Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.

Authors:  Yoshiko Watanabe; Fuminori Katou; Haruo Ohtani; Takashi Nakayama; Osamu Yoshie; Kenji Hashimoto
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-03-29

2.  CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).

Authors:  Panagiotis Balermpas; Franz Rödel; Claus Rödel; Mechthild Krause; Annett Linge; Fabian Lohaus; Michael Baumann; Inge Tinhofer; Volker Budach; Eleni Gkika; Martin Stuschke; Melanie Avlar; Anca-Lidia Grosu; Amir Abdollahi; Jürgen Debus; Christine Bayer; Stefan Stangl; Claus Belka; Steffi Pigorsch; Gabriele Multhoff; Stephanie E Combs; David Mönnich; Daniel Zips; Emmanouil Fokas
Journal:  Int J Cancer       Date:  2015-07-30       Impact factor: 7.396

3.  Prognostic markers in oropharyngeal squamous cell carcinoma: focus on CD70 and tumour infiltrating lymphocytes.

Authors:  Astrid De Meulenaere; Tijl Vermassen; Sandrine Aspeslagh; Karen Zwaenepoel; Philippe Deron; Fréderic Duprez; Sylvie Rottey; Liesbeth Ferdinande
Journal:  Pathology       Date:  2017-04-17       Impact factor: 5.306

Review 4.  CD8+ T-cell memory in tumor immunology and immunotherapy.

Authors:  Christopher A Klebanoff; Luca Gattinoni; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2006-06       Impact factor: 12.988

5.  Radiochemotherapy induces a favourable tumour infiltrating inflammatory cell profile in head and neck cancer.

Authors:  M Tabachnyk; L V R Distel; M Büttner; G G Grabenbauer; E Nkenke; R Fietkau; D Lubgan
Journal:  Oral Oncol       Date:  2012-02-21       Impact factor: 5.337

6.  Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma.

Authors:  E Zancope; N L Costa; A P Junqueira-Kipnis; M C Valadares; T A Silva; C R Leles; E F Mendonça; A C Batista
Journal:  J Oral Pathol Med       Date:  2009-09-14       Impact factor: 4.253

7.  Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study.

Authors:  Gregory T Wolf; Douglas B Chepeha; Emily Bellile; Ariane Nguyen; Daffyd Thomas; Jonathan McHugh
Journal:  Oral Oncol       Date:  2014-10-03       Impact factor: 5.337

8.  CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma.

Authors:  Cecilia Nordfors; Nathalie Grün; Nikolaos Tertipis; Andreas Ährlund-Richter; Linnea Haeggblom; Lars Sivars; Juan Du; Tommy Nyberg; Linda Marklund; Eva Munck-Wikland; Anders Näsman; Torbjörn Ramqvist; Tina Dalianis
Journal:  Eur J Cancer       Date:  2013-04-06       Impact factor: 9.162

9.  Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Authors:  Ellen L Goode; Matthew S Block; Kimberly R Kalli; Robert A Vierkant; Wenqian Chen; Zachary C Fogarty; Aleksandra Gentry-Maharaj; Aleksandra Tołoczko; Alexander Hein; Aliecia L Bouligny; Allan Jensen; Ana Osorio; Andreas Hartkopf; Andy Ryan; Anita Chudecka-Głaz; Anthony M Magliocco; Arndt Hartmann; Audrey Y Jung; Bo Gao; Brenda Y Hernandez; Brooke L Fridley; Bryan M McCauley; Catherine J Kennedy; Chen Wang; Chloe Karpinskyj; Christiani B de Sousa; Daniel G Tiezzi; David L Wachter; Esther Herpel; Florin Andrei Taran; Francesmary Modugno; Gregg Nelson; Jan Lubiński; Janusz Menkiszak; Jennifer Alsop; Jenny Lester; Jesús García-Donas; Jill Nation; José Palacios; Joseph H Rothstein; Joseph L Kelley; Jurandyr M de Andrade; Luis Robles-Díaz; Maria P Intermaggio; Martin Widschwendter; Matthias W Beckmann; Matthias Ruebner; Mercedes Jimenez-Linan; Naveena Singh; Oleg Oszurek; Paul R Harnett; Peter F Rambau; Peter Sinn; Philipp Wagner; Prafull Ghatage; Raghwa Sharma; Robert P Edwards; Roberta B Ness; Sandra Orsulic; Sara Y Brucker; Sharon E Johnatty; Teri A Longacre; Eilber Ursula; Valerie McGuire; Weiva Sieh; Yanina Natanzon; Zheng Li; Alice S Whittemore; deFazio Anna; Annette Staebler; Beth Y Karlan; Blake Gilks; David D Bowtell; Estrid Høgdall; Francisco J Candido dos Reis; Helen Steed; Ian G Campbell; Jacek Gronwald; Javier Benítez; Jennifer M Koziak; Jenny Chang-Claude; Kirsten B Moysich; Linda E Kelemen; Linda S Cook; Marc T Goodman; María José García; Peter A Fasching; Stefan Kommoss; Suha Deen; Susanne K Kjaer; Usha Menon; James D Brenton; Paul DP Pharoah; Georgia Chenevix-Trench; David G Huntsman; Stacey J Winham; Martin Köbel; Susan J Ramus
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 33.006

10.  Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma.

Authors:  Simona Partlová; Jan Bouček; Kamila Kloudová; Eva Lukešová; Michal Zábrodský; Marek Grega; Jitka Fučíková; Iva Truxová; Ruth Tachezy; Radek Špíšek; Anna Fialová
Journal:  Oncoimmunology       Date:  2015-01-30       Impact factor: 8.110

View more
  14 in total

1.  Spatial Profiles of Intratumoral PD-1+ Helper T Cells Predict Prognosis in Head and Neck Squamous Cell Carcinoma.

Authors:  Kanako Yoshimura; Takahiro Tsujikawa; Junichi Mitsuda; Hiroshi Ogi; Sumiyo Saburi; Gaku Ohmura; Akihito Arai; Saya Shibata; Guillaume Thibault; Young Hwan Chang; Daniel R Clayburgh; Satoru Yasukawa; Aya Miyagawa-Hayashino; Eiichi Konishi; Kyoko Itoh; Lisa M Coussens; Shigeru Hirano
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

2.  Automated Nuclear Segmentation in Head and Neck Squamous Cell Carcinoma Pathology Reveals Relationships between Cytometric Features and ESTIMATE Stromal and Immune Scores.

Authors:  Stephanie J Blocker; James Cook; Jeffrey I Everitt; Wyatt M Austin; Tammara L Watts; Yvonne M Mowery
Journal:  Am J Pathol       Date:  2022-06-17       Impact factor: 5.770

Review 3.  [Comparison of T cell response in the tumor milieu of patients with HPV+ and HPV- head and neck cancer].

Authors:  T Bastian; S Lang; B A Kansy
Journal:  HNO       Date:  2020-02       Impact factor: 1.284

4.  Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck.

Authors:  Dan P Zandberg; Ashley V Menk; Maria Velez; Daniel Normolle; Kristin DePeaux; Angen Liu; Robert L Ferris; Greg M Delgoffe
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

Review 5.  Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.

Authors:  Juan P Rodrigo; Mario Sánchez-Canteli; Fernando López; Gregory T Wolf; Juan C Hernández-Prera; Michelle D Williams; Stefan M Willems; Alessandro Franchi; Andrés Coca-Pelaz; Alfio Ferlito
Journal:  Biomedicines       Date:  2021-04-28

6.  MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling.

Authors:  Hoi-Lam Ngan; Yuchen Liu; Andrew Yuon Fong; Peony Hiu Yan Poon; Chun Kit Yeung; Sharon Suet Man Chan; Alexandria Lau; Wenying Piao; Hui Li; Jessie Sze Wing Tse; Kwok-Wai Lo; Sze Man Chan; Yu-Xiong Su; Jason Ying Kuen Chan; Chin Wang Lau; Gordon B Mills; Jennifer Rubin Grandis; Vivian Wai Yan Lui
Journal:  Life Sci Alliance       Date:  2020-05-07

7.  Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma.

Authors:  Pok Fai Wong; Wei Wei; Swati Gupta; James W Smithy; Daniel Zelterman; Harriet M Kluger; David L Rimm
Journal:  J Immunother Cancer       Date:  2019-07-23       Impact factor: 13.751

8.  Quantitative Image Analysis for Tissue Biomarker Use: A White Paper From the Digital Pathology Association.

Authors:  Haydee Lara; Zaibo Li; Esther Abels; Famke Aeffner; Marilyn M Bui; Ehab A ElGabry; Cleopatra Kozlowski; Michael C Montalto; Anil V Parwani; Mark D Zarella; Douglas Bowman; David Rimm; Liron Pantanowitz
Journal:  Appl Immunohistochem Mol Morphol       Date:  2021-08-01

9.  Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer.

Authors:  Nanna Jørgensen; Thomas Vauvert F Hviid; Lise B Nielsen; Ida M H Sønderstrup; Jens Ole Eriksen; Bent Ejlertsen; Anne-Marie Gerdes; Torben A Kruse; Mads Thomassen; Maj-Britt Jensen; Anne-Vibeke Lænkholm
Journal:  Br J Cancer       Date:  2021-08-07       Impact factor: 9.075

10.  Automated Quantitation of CD8-positive T Cells Predicts Prognosis in Colonic Adenocarcinoma With Mucinous, Signet Ring Cell, or Medullary Differentiation Independent of Mismatch Repair Protein Status.

Authors:  Douglas J Hartman; Madison Frank; Lindsey Seigh; Haroon Choudry; James Pingpank; Matthew Holtzman; David Bartlett; Nathan Bahary; Liron Pantanowitz; Reetesh K Pai
Journal:  Am J Surg Pathol       Date:  2020-07       Impact factor: 6.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.